Sulfadiazine
|
Product Name |
|||||||||
|
Synonyms |
4-Amino-N-2-pyrimidinyl-benzenesulfonamide; N1-(2-Pyrimidinyl)-sulfanilamide |
||||||||
|
CAS |
|||||||||
|
Molecular formula |
C10H10N4O2S |
||||||||
|
Molecular Weight |
250.27 |
||||||||
|
Molecular Structure |
 |
||||||||
|
Physical and Chemical Properties |
|
||||||||
|
General Description |
White or off-white crystals or powders |
||||||||
|
Usage |
For the excellent varieties of sulfa, the antibacterial effect is stronger, the curative effect is better, the absorption is faster, the excretion is slower, and the effective concentration is higher in the blood. Clinical use is used to treat upper respiratory tract infection. Epidemic meningitis, otitis media, furuncle carbuncle, puerperal fever, urethral infection and acute mycordysentery. |
||||||||
|
Packing |
25/drum |
||||||||
|
Specifications |
|||||||||
|
Items |
Standard |
||||||||
|
Appearance |
White or off-white crystal or powder |
||||||||
|
Identification |
(1) (2) (3) shall comply with |
||||||||
|
Acidity |
≤0.1mol/L NaOH 0.2ml |
||||||||
|
Clarity and color of alkaline solution |
Clear |
||||||||
|
Chloride |
≤0.01% |
||||||||
|
Loss on drying |
≤0.5% |
||||||||
|
Residue on ignition |
≤0.1% |
||||||||
|
Heavy metal |
No more than ten over 10 PPM |
||||||||
|
Content (Anhydrous substance) |
≥99.0% |
||||||||
|
Related substances |
≤0.5% (TLC) |
||||||||
